These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2353864)

  • 21. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of hypolipemic effects of lovastatin and gemfibrozil].
    Gavelli MS; Vitaliano E; Rossi FG; Serra T; Santini G; Bernardi G
    Clin Ter; 1991 Jan; 136(1):31-8. PubMed ID: 1826871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low plasma lipid levels and increased cholesterol synthesis after partial ileal bypass plus lovastatin in hypercholesterolemic rabbits.
    Tijerina O; Dombrovskis S; Esper E; Matts JP; Campos CT; Buchwald H
    Surgery; 1988 Oct; 104(4):796-805. PubMed ID: 3175875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gemfibrozil in hyperlipidaemia: an open, single blind trial.
    Varthakavi PK; Turakhia DP; Sharma SS; Salgaonkar DS; Nihalani KD; Joshi VR
    J Assoc Physicians India; 1990 Feb; 38(2):136-40. PubMed ID: 2380132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation.
    Zambón D; Ros E; Rodriguez-Villar C; Laguna JC; Vázquez M; Sanllehy C; Casals E; Sol JM; Hernández G
    Metabolism; 1999 Jan; 48(1):47-54. PubMed ID: 9920144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia.
    Lamendola C; Abbasi F; Chu JW; Hutchinson H; Cain V; Leary E; McLaughlin T; Stein E; Reaven G
    Am J Cardiol; 2005 Jan; 95(2):189-93. PubMed ID: 15642550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
    Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
    Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
    Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective review of the use of lipid-lowering agents in combination, specifically, gemfibrozil and lovastatin.
    Wirebaugh SR; Shapiro ML; McIntyre TH; Whitney EJ
    Pharmacotherapy; 1992; 12(6):445-50. PubMed ID: 1492008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of combined gemfibrozil-lovastatin therapy for primary dyslipoproteinemias.
    Glueck CJ; Speirs J; Tracy T
    J Lab Clin Med; 1990 May; 115(5):603-9. PubMed ID: 2341762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary hypertriglyceridemia with borderline high cholesterol and elevated apolipoprotein B concentrations. Comparison of gemfibrozil vs lovastatin therapy.
    Vega GL; Grundy SM
    JAMA; 1990 Dec; 264(21):2759-63. PubMed ID: 2232062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination drug therapy for familial combined hyperlipidemia.
    East C; Bilheimer DW; Grundy SM
    Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism.
    Vega GL; Grundy SM
    Kidney Int; 1988 Jun; 33(6):1160-8. PubMed ID: 3165483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of combined hyperlipidemia with lovastatin versus gemfibrozil: a comparison study.
    Ojala JP; Helve E; Tikkanen MJ
    Cardiology; 1990; 77 Suppl 4():39-49. PubMed ID: 2073671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of lovastatin and gemfibrozil in subjects with high ratios of total cholesterol to high-density lipoprotein cholesterol.
    Hung YJ; Pei D; Wu DA; Kuo SW; Fuh MM; Jeng C
    J Formos Med Assoc; 1999 Feb; 98(2):104-10. PubMed ID: 10083765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of lovastatin on serum lipids in patients with primary hyperlipidemia phenotype IIa and IIb. I. Efficacy of lovastatin in the treatment of hyperlipoproteinemia].
    Idzior-Waluś B
    Przegl Lek; 1992; 49(9):287-91. PubMed ID: 1302351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia.
    D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
    Am J Cardiol; 1992 Jan; 69(1):28-34. PubMed ID: 1729864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
    Aguilar-Salinas CA; Fanghänel-Salmón G; Meza E; Montes J; Gulías-Herrero A; Sánchez L; Monterrubio-Flores EA; González-Valdez H; Gómez Pérez FJ
    Metabolism; 2001 Jun; 50(6):729-33. PubMed ID: 11398153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
    Lane DM; Alaupovic P; Knight-Gibson C; Dudley VS; Laughlin LO
    Am J Cardiol; 1995 Jun; 75(16):1124-9. PubMed ID: 7762498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia.
    Illingworth DR; Bacon S
    Circulation; 1989 Mar; 79(3):590-6. PubMed ID: 2645064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males.
    Cuchel M; Schaefer EJ; Millar JS; Jones PJ; Dolnikowski GG; Vergani C; Lichtenstein AH
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1910-7. PubMed ID: 9351353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.